COVID Vaccine Problems Media Articles
Below are key excerpts of revealing news articles on COVID vaccine problems from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.
A convoy of big rigs has arrived in the national capital to protest vaccine mandates and Covid-19 measures. It's been dubbed the Freedom Convoy. The movement was sparked by a vaccine mandate for truckers crossing the US-Canada border, implemented by Prime Minister Justin Trudeau's Liberal government earlier this month. Upset with the new measure that would require unvaccinated Canadian truckers crossing the two nations' boundary to quarantine once they've returned home, a loose coalition of truckers and conservative groups began to organise the cross-country drive that began in western Canada. It picked up steam and gathered support as it drove east. Many supporters, already opposed to Mr Trudeau and his politics, have grown frustrated with pandemic measures they see as political overreach. Social media and news footage showed trucks and companion vehicles snaking along highways, cheered on by people gathered on roadsides and overpasses, often waving Canadian flags and signs disparaging Mr Trudeau. A GoFundMe campaign has raised, to date, over a whopping C$7m ($5.4m; £4m) from over 99,000 donors. "We want to be free, we want to have our choice again, and we want hope - and the government has taken that away," Harold Jonker, a truck driver and trucking company owner, told the BBC. Mr Trudeau this week denounced the convoy and its supporters as a "small fringe minority". But the convoy has received some support from Conservative politicians.
Note: If you look at MSM reporting, the vast majority of report put a negative spin on this. And you can bet that agent provocateurs have been sent to cause trouble then blamed on the protest. Facebook removed the Freedom Convoy page while GoFundMe stopped donations to the group. What gives them the right to do this? For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Almost 500 U.S. service members have been discharged so far for refusing the COVID-19 vaccine. But that number is likely to climb as the various military branches continue the process of dealing with those who are refusing to get vaccinated against COVID-19, or have requested exemptions. The Navy said on Tuesday that it has discharged 23 active-duty sailors for refusing the coronavirus vaccine. The Air Force, as of January 21, has discharged 111 active-duty airmen. As of January 20, the Marine Corps had discharged 334 Marines. The Army is the only service that has not yet initiated separations for active-duty personnel for refusing the COVID-19 vaccine. But in a news release earlier this month, the Army said it had relieved six active-duty leaders, including two battalion commanders, from their positions for refusing the vaccine. The Army also said it had issued almost 3,000 general officer written reprimands to soldiers for vaccine refusal. The 2022 National Defense Authorization Act, which President Joe Biden signed into law in December, prohibits service members from being dishonorably discharged for refusing to get the COVID-19 vaccine. Last summer, the Department of Defense announced that it would make COVID-19 vaccination mandatory for all service members—active-duty, National Guard and Reserves. Around 98 percent of active-duty service members are fully vaccinated, according to the Department of Defense.
Note: This 3-minute video features a hearing where data was given by Dept. of Defense whistleblowers reporting on the health of US soldiers. The data clearly shows that neurological problems among troops increased by 10 times (1,000%) over previous years. Other disease also had major increases. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Pfizer Inc wants to intervene in a Texas federal lawsuit seeking information from the U.S. Food and Drug Administration used in licensing the company's COVID-19 vaccine, a litigation move that plaintiffs who are suing for the data say is premature. Pfizer's lawyers at DLA Piper told U.S. District Judge Mark Pittman on Jan. 21 it wanted a role in the proceedings to help the FDA avoid "inappropriately" disclosing trade secret and confidential commercial information. On Tuesday night, the group of doctors and scientists who sued last year over public access to the FDA's Pfizer licensing records said in a court filing that the company's bid to jump into the lawsuit was untimely because the plaintiffs have not challenged any redactions to requested records. Earlier this month, the judge ordered a fast-track release of hundreds of thousands of documents, calling the case "of paramount public importance." U.S. government agencies control the release of information under federal public-records laws, but companies can challenge and even sue to block the disclosure of certain details. The FDA earlier drew criticism over its plan to release 500 pages a month in response to the lawsuit from Public Health and Medical Professionals for Transparency, a production schedule that would take more than 50 years to complete. In its filing, Pfizer said the company supports public disclosure of FDA records "to promote transparency and the public's confidence in the vaccine."
Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and coronavirus vaccines from reliable major media sources.
Austrian lawmakers on Thursday voted 137-33 in favor of a COVID-19 mandate that requires all residents 18 and older to be vaccinated. The mandate, which will go into effect on February 1, will allow fines of up to $4,000 for noncompliance. Officials said the mandate is necessary since Austria's vaccination rate is one of the lowest in Western Europe. Our World Data reported that 74 percent of the country is vaccinated. Austria ... has had four lockdowns. AP reported that police will routinely check vaccination status, and those who cannot show proof of vaccination will first receive a warning and then be fined $685 if they don't comply. Chancellor Karl Nehammer said the government also plans to send unvaccinated individuals vaccine appointments and will be fined if they don't show up. Vaccination exemptions will be made for pregnant women, people who cannot get vaccinated for medical reasons and people who have recovered from coronavirus somewhere in the past six months. There will also be $1.59 billion invested into incentives to encourage unvaccinated people to get the shot. Since the mandate was first announced, there have been large protests in Vienna, drawing more than 40,000 people. The mandate is the first of its kind in Europe. Italy and Greece made the COVID-19 vaccine mandatory for ages 50-plus and 60-plus, respectively. The Austrian mandate is expected to stay in place until January of 2024.
Note: Greece is also issuing monthly fines to older people who don’t get a vaccine. The government can now mandate what is put in your body when we don't even know the long-term effects. Is this is moral and ethical? For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
In the pages of The BMJ a decade ago, in the middle of a different pandemic, it came to light that governments around the world had spent billions stockpiling antivirals for influenza that had not been shown to reduce the risk of complications, hospital admissions, or death. The errors of the last pandemic are being repeated. Memories are short. Today, despite the global rollout of covid-19 vaccines and treatments, [the] data underlying the trials for these new products remain inaccessible to doctors, researchers, and the public—and are likely to remain that way for years to come. This is morally indefensible for all trials, but especially for those involving major public health interventions. Pfizer’s pivotal covid vaccine trial was funded by the company and designed, run, analysed, and authored by Pfizer employees. The company and the contract research organisations that carried out the trial hold all the data. And Pfizer has indicated that it will not begin entertaining requests for trial data until May 2025, 24 months after the primary study completion date. The lack of access to data is consistent across vaccine manufacturers. Regulators and public health bodies could release details such as why vaccine trials were not designed to test efficacy against infection and spread of SARS-CoV-2. Had regulators insisted on this outcome, countries would have learnt sooner about the effect of vaccines on transmission and been able to plan accordingly.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Previous infection with the coronavirus appeared to provide stronger protection against the Delta variant than did vaccination in a large sample of patients, the Centers for Disease Control and Prevention reported. Scientists analyzed testing, surveillance and immunization data from the [New York and California] to gauge the level of protection offered by vaccines and previous infection. During the week beginning May 30, 2021, vaccinated people who had not experienced Covid had the lowest risk of coronavirus infection and hospitalization, followed by unvaccinated people who had been previously diagnosed with Covid. By the week beginning Oct. 3, however, vaccinated people with a prior diagnosis fared best against the Delta variant. Unvaccinated people with a history of Covid also had lower rates of infection and hospitalization than those protected by vaccines alone. Waning of vaccine-derived immunity may explain why vaccinated people were less protected from infection with the Delta variant than those who had a prior diagnosis. A recent study of employees at the Cleveland Clinic suggested that ... vaccination does not add much benefit to a prior bout for the first many months.
Note: The full article is strongly biased towards vaccination, yet the data shows that prior exposure to COVID often provides better protection than the vaccines, whose protection clearly wanes over time. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Previous infection with the coronavirus appeared to provide stronger protection against the Delta variant than did vaccination in a large sample of patients, the Centers for Disease Control and Prevention reported. Scientists analyzed testing, surveillance and immunization data from the [New York and California] to gauge the level of protection offered by vaccines and previous infection. During the week beginning May 30, 2021, vaccinated people who had not experienced Covid had the lowest risk of coronavirus infection and hospitalization, followed by unvaccinated people who had been previously diagnosed with Covid. By the week beginning Oct. 3, however, vaccinated people with a prior diagnosis fared best against the Delta variant. Unvaccinated people with a history of Covid also had lower rates of infection and hospitalization than those protected by vaccines alone. Waning of vaccine-derived immunity may explain why vaccinated people were less protected from infection with the Delta variant than those who had a prior diagnosis. A recent study of employees at the Cleveland Clinic suggested that ... vaccination does not add much benefit to a prior bout for the first many months.
Note: The full article is strongly biased towards vaccination, yet the data shows that prior exposure to COVID often provides better protection than the vaccines, whose protection clearly wanes over time. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
The Supreme Court’s ruling last week shutting down the Biden administration’s effort to enlist large employers in its vaccination campaign, experts said, would trigger a new wave of uncertainty about how companies keep workers safe from Covid-19. Now Starbucks, with 9,000 U.S. coffee shops and 200,000 workers, has become one of the first major retailers to backtrack on vaccine plans since the ruling. Starbucks told its employees in a memo on Tuesday that they would no longer be required to be fully vaccinated or submit to weekly coronavirus testing. Just two weeks earlier, the company had detailed the requirement and set a deadline of Feb. 9. The Supreme Court’s decision did not prohibit companies from keeping their vaccine rules in place, and many will continue rolling out stringent Covid-19 safety protocols, especially as Covid case counts remain high. Starbucks’s move to drop its vaccine-or-test deadline highlights how the court’s ruling has put the responsibility for determining vaccination rules squarely on employers. And companies face a patchwork of federal, state and local laws, which range from vaccine mandates that are stricter than the federal government’s to laws blocking companies from requiring workers to wear masks. Retailers and their advocates had been among the most vocal critics of the federal government’s vaccine rule, saying it would have exacerbated their struggles to hire or hold on to workers when millions of unemployed Americans remain on the sidelines of the job market.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
After raking in enormous profits from its coronavirus vaccine in 2021, the U.S.-based pharmaceutical giant Pfizer has kicked off the new year by hiking the prices of more than 120 of its drugs, resulting in significantly higher costs for patients amid a deadly pandemic. That's according to a new report released Thursday by Patients for Affordable Drugs (P4AD), which found that pharmaceutical companies have raised the prices of 554 medicines this month alone. Pfizer led the way with 125 price hikes to start 2022, leading P4AD to label the company the industry's "poster child for greed." "Due to sales of its Covid-19 vaccine, which is set to be the best-selling drug of all time, Pfizer shattered profit records in 2021. Projected sales for 2022 are $54.5 billion—more than double the previous record for one-year sales for a prescription drug," the report notes. "To put this into perspective, AbbVie's Humira previously held the spot with $19.8 billion in sales, and Pfizer’s best-selling product just prior to the pandemic achieved worldwide revenues of $5.8 billion." "Despite this record revenue in 2021," the report continues, "Pfizer began 2022 with price hikes on seven of its 10 best-selling drugs," including its pneumonia vaccine (up 6.9%), a breast cancer medication (up 6.9%), and a treatment for people with cardiovascular disease (up 6%). "These hikes of 5% or 6% can translate into thousands of dollars in higher costs for patients," P4AD notes.
Note: See also a Forbes article asking why physicians aren’t challenging outrageous pricing for medical costs. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.
European Union regulators warned that frequent Covid-19 booster shots could adversely affect the immune response and may not be feasible. Repeat booster doses every four months could eventually weaken the immune response and tire out people, according to the European Medicines Agency. Instead, countries should leave more time between booster programs and tie them to the onset of the cold season in each hemisphere, following the blueprint set out by influenza vaccination strategies, the agency said. The advice comes as some countries consider the possibility of offering people second booster shots in a bid to provide further protection against surging omicron infections. Earlier this month Israel became the first nation to start administering a second booster, or fourth shot, to those over 60. The U.K. has said that boosters are providing good levels of protection and there is no need for a second booster shot at the moment, but will review data as it evolves. Boosters “can be done once, or maybe twice, but it’s not something that we can think should be repeated constantly,” Marco Cavaleri, the EMA head of biological health threats and vaccines strategy, said at a press briefing on Tuesday. “We need to think about how we can transition from the current pandemic setting to a more endemic setting.”
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
The director for the CDC publicly acknowledged in a CNN interview that the COVID-19 vaccine is not effective at preventing transmission of the virus. In a segment on CNN with Wolf Blitzer, Walensky said that while the vaccines are doing very well to protect against serious illness and death, what they cannot do anymore is stop transmission. “Our vaccines are working exceptionally well. They continue to work well for Delta with regard to severe illness and death. They prevent it," Walensky said. The following statement is more notable, however, as it is one of the only times the CDC has acknowledged that the vaccines are not capable of stopping the spread of the virus. "...what they can’t do anymore is prevent transmission" ... Walensky stated.
Note: Why did many officials state emphatically early on that vaccines were the only thing that would stop the pandemic when they do not stop transmission of the virus? Doesn't this show the vaccine mandates were a sham? A BMJ (British Medical Journal) article states “Vaccines aren’t preventing onward transmission by reducing the viral load—or amount of SARS-CoV-2—in your body.” For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Pfizer CEO Albert Bourla on Monday said two doses of the company’s vaccine may not provide strong protection against infection from the Covid omicron variant, and the original shots have also lost some of their efficacy at preventing hospitalization. Bourla, in an interview at JPMorgan’s health-care conference, emphasized the importance of a third shot to boost people’s protection against omicron. “The two doses, they’re not enough for omicron,” Bourla said. “The third dose of the current vaccine is providing quite good protection against deaths, and decent protection against hospitalizations.” Bourla said omicron is a more difficult target than previous variants. Omicron, which has dozens of mutations, can evade some of the protection provided by Pfizer’s original two shots. Two-doses of Pfizer’s or Moderna’s vaccines are only about 10% effective at preventing infection from omicron 20 weeks after the second dose. A booster dose ... is up to 75% effective at preventing symptomatic infection and 88% effective at preventing hospitalization. However ... the U.K. Health Security Agency also found that boosters are only 40% to 50% effective against infection 10 weeks after receiving the shot.
Note: What happened to the 95% effectiveness touted highly in the beginning? Why weren't we told that the vaccines could lose most of their efficacy over time? Does this mean we'll need a new vaccine with every new variant? And of course, this means more billions flowing into the pockets of big Pharma. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
A federal judge in Texas on Thursday ordered the Food and Drug Administration to make public the data it relied on to license Pfizer’s COVID-19 vaccine, imposing a dramatically accelerated schedule that should result in the release of all information within about eight months. That’s roughly 75 years and four months faster than the FDA said it could take to complete a Freedom of Information Act request by a group of doctors and scientists seeking an estimated 450,000 pages of material about the vaccine. The court “concludes that this FOIA request is of paramount public importance,” wrote U.S. District Judge Mark Pittman. The FDA didn’t dispute it had an obligation to make the information public but argued that its short-staffed FOIA office only had the bandwidth to review and release 500 pages a month. While Pittman recognized “the ‘unduly burdensome’ challenges that this FOIA request may present to the FDA,” in his four-page order, he resoundingly rejected the agency’s suggested schedule. Rather than producing 500 pages a month — the FDA's proposed timeline — he ordered the agency to turn over 55,000 a month. That means all the Pfizer vaccine data should be public by the end of the summer rather than, say, the year 2097. Aaron Siri of Siri & Glimstad, who represents the plaintiffs, in an email said the decision "came down on the side of transparency and accountability." His clients ... have pledged to publish all the information they receive from the FDA on their website.
Note: Why did almost no major media pick up this important article? And read this revealing article on 800 individuals who Pfizer reported withdrew from their vaccine studies, some because of health problems which could have been caused by the vaccine. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
Millions of doses of a new, cheap coronavirus vaccine will soon be available in India, and they will arrive with one distinction neither Moderna nor Pfizer can claim: They’re patent-free. The new CORBEVAX inoculation, which was developed in Texas with decades-old technology and little support from the U.S. government, received emergency use authorization last week from India’s drug regulation agency. The researchers behind the vaccine stand with little to gain financially. “We don’t own any intellectual property,” said Dr. Peter Hotez, a researcher who helped lead the vaccine’s development. Human rights campaigners are pressuring pharmaceutical companies to transfer new vaccine technology to speed global access to shots. And while doubts linger about CORBEVAX ... its development, outside the path of typical pharmaceutical development and stripped of the same financial incentives for inventors, represents a model for others. About 59 percent of the world’s population has received at least one dose of a vaccine. But fewer than 9 percent of residents in low-income countries have received a dose. To this day, countries like India remain without access to the mRNA vaccines produced by Pfizer-BioNTech and Moderna, which have largely been purchased and distributed by wealthy countries. Boosters, and even fourth doses, are being administered in rich countries before access to first and second doses are available worldwide.
Note: In this time of crisis, why is big Pharma raking in huge profits while wonderful researchers like this are offering their findings free of charge? Why in every recent pandemic do the rich get richer while the financially disadvantaged suffer. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
A year ago, just two doses of a Covid-19 vaccine — or even one, in the case of Johnson & Johnson’s formulation — were thought to offer sufficient protection against the coronavirus. On Wednesday, the Centers for Disease Control and Prevention expanded eligibility for boosters to adolescents and backed away from describing anyone as “fully vaccinated” because two shots no longer seem adequate. Instead, one’s vaccination status will now be “up to date” — or not. It’s no surprise that many Americans are wondering: Where does this end? Are we to roll up our sleeves for booster shots every few months? Scientists are reluctant to predict the future. But in interviews this week, nearly a dozen said that whatever happens, trying to boost the entire population every few months is not realistic. Nor does it make much scientific sense. For starters, persuading people to line up for shots every few months is probably a losing proposition. Just as important, there are no data to support the effectiveness of a fourth dose of the current vaccines. If the coronavirus settles into a flulike seasonal pattern, as it seems possible, “you can imagine a scenario where we simply give boosters before the winter each year,” Dr. Hensley said. Lessons from flu season also suggest that frequent vaccination is unlikely to be helpful. Giving the flu vaccine twice a year “has a diminishing return, and so it may not make sense to do vaccination so frequently,” said [epidemiologist] Ben Cowling.
Note: Could it be that this is what big Pharma has been hoping for all along - forever boosting? And if it’s all free, you won’t even see how billions of your tax dollars are flowing into the pockets of the elite. Could this be why the Australian government on their website stated they are securing 195 million doses of COVID vaccine boosters for their population of 25 million? For more, see this revealing article. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
The digital Covid vaccination certification, or “passport,” is a mobile app that instantaneously affirms the vaccinated status, Covid test results, birth date, gender, and/or other identifiers of its holder. The information is usually mosaicked in a QR code, read by a proprietary scanner, and linked to a government registry. Led by New York, California, and Louisiana, as many as 30 states are rolling them out. The Biden administration announced last spring that it would wrangle them under national standards but so far it hasn’t. Internationally, the EU and a growing number of countries are adopting them, from repressive regimes like Bahrain to democracies like Denmark. Twenty U.S. states have banned the passes, and hashtags like #NoVaccinePassports are proliferating. “Spoiler alert,” tweeted British DJ ... Lange. “They are not planning on removing vax passports once introduced. This is just the first step to get you conditioned to accepting government restrictions in your daily life via your mobile phone. This digital ID is going to expand to all aspects of your life.” New York, for one, is not expecting to mothball the technology when Covid wanes. State bureaucrats are “exploring how the platform could be retrofitted to verify other types of records and credentials.” The surveillance technologies of the War on Contagion are inherited from the War on Terror, and the software is encoded with the same forever-war mentality: Both fight risk rather than actual threat.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines and the disappearance of privacy from reliable major media sources.
The digital Covid vaccination certification, or “passport,” is a mobile app that instantaneously affirms the vaccinated status, Covid test results, birth date, gender, and/or other identifiers of its holder. The information is usually mosaicked in a QR code, read by a proprietary scanner, and linked to a government registry. Led by New York, California, and Louisiana, as many as 30 states are rolling them out. The Biden administration announced last spring that it would wrangle them under national standards but so far it hasn’t. Internationally, the EU and a growing number of countries are adopting them, from repressive regimes like Bahrain to democracies like Denmark. Twenty U.S. states have banned the passes, and hashtags like #NoVaccinePassports are proliferating on both sides of the Atlantic. “Spoiler alert,” tweeted British DJ ... Lange. “They are not planning on removing vax passports once introduced. This is just the first step to get you conditioned to accepting government restrictions in your daily life via your mobile phone. This digital ID is going to expand to all aspects of your life.” Evidence supports the detractors’ suspicions. Every government introducing a vaccine certification vows that their use is voluntary and no personal information will be held beyond its necessity. But governments are far from unanimous even on such basics as ... how long and by whom our intimate information will be held, owned, or overseen. New York, for one, is not expecting to mothball the technology when Covid wanes.
Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines and the disappearance of privacy from reliable major media sources.
Microchip technology invented by Swedish startup company "Epicenter" is now being presented as a possible way to carry around a COVID-19 vaccine passport under a person's skin, according to a viral video. "Beep boop beep: Your vaccination record has been verified," says the caption of the video. "Imagine showing your COVID-19 passport with just a flash of your arm," the video says at its beginning, showing a person holding out their arm and scanning it with a mobile phone. The video explains the microchip uses pre-existing technology the startup company was already developing to employ "near-field communication" (NFC) and send data to any compatible device. Smartphones are listed as an example of a possible data receiver. "Implants are a very versatile technology that can be used for many different things," says Epicenter's Chief Disruption Officer Hannes Sjoblad in the video. "Right now it is very convenient to have a COVID passport always accessible on your implant." A microchip, about the size of a grain of rice, can be embedded under a person's skin, either under the arm or between the pointer finger and thumb, according to Sjoblad. After the chip is implanted, data such as a vaccine passport can be stored on it using NFC-compatible devices. There is pushback on implants from lawmakers, advocacy groups, and the public. Hannes Sjoblad reportedly organized "transplant parties" for his employees starting in 2014, where they would gather in a fun, social setting to get chips embedded into themselves.
Note: According to this article, "At the beginning of December, Sweden enacted new rules requiring individuals to have a passport at all events with more than 100 people. Following that announcement, the number of people who got microchips inserted under their skin rose: around 6,000 people in Sweden have so far had a chip inserted in their hands." For more along these lines, see concise summaries of deeply revealing news articles on microchip implants from reliable major media sources.
High COVID-19 vaccination rates were expected to reduce transmission of SARS-CoV-2 in populations by reducing the number of possible sources for transmission and thereby to reduce the burden of COVID-19 disease. Recent data, however, indicate that the epidemiological relevance of COVID-19 vaccinated individuals is increasing. In the UK it was described that secondary attack rates among household contacts exposed to fully vaccinated index cases was similar to household contacts exposed to unvaccinated index cases (25% for vaccinated vs 23% for unvaccinated). 12 of 31 infections in fully vaccinated household contacts (39%) arose from fully vaccinated epidemiologically linked index cases. Between week 39 and 42, a total of 100.160 COVID-19 cases were reported among citizens of 60 years or older. 89.821 occurred among the fully vaccinated (89.7%), 3.395 among the unvaccinated (3.4%). One week before, the COVID-19 case rate per 100.000 was higher among the subgroup of the vaccinated compared to the subgroup of the unvaccinated. The [CDC] identifies four of the top five counties with the highest percentage of fully vaccinated population (99.9–84.3%) as “high” transmission counties. It appears to be grossly negligent to ignore the vaccinated population as a possible and relevant source of transmission.
Note: This paper in the UK's highly esteemed Lancet shows that the vaccines are not stopping the spread of infection of COVID. They clearly are greatly decreasing the number of hospitalizations and deaths among the vaccinated, but they are not helping to stop the spread of this virus. For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.
A journalist writing for The BMJ has won a British Journalism Award for his series on the financial interests of medical experts advising US and UK governments during the covid-19 pandemic. As a result of the articles written by Paul Thacker, an investigative journalist, the financial disclosures of members of the Scientific Advisory Group for Emergencies (SAGE) were published for the first time. Thacker’s first story looked at two groups critical to the UK government’s pandemic response—SAGE and the Vaccine Taskforce. He examined both and found that they did not disclose their members’ financial conflicts. Some members were tied to companies with a monetary interest in the government’s purchases. Thacker ... filed freedom of information (FoI) requests with multiple government departments and Oxford University. In a second story he wrote about the government’s repeated refusal to turn over these data. However, the FoI ... revealed that Thacker’s original request was apparently sent to a special government department to handle any reporter considered a “campaigner” or to have “extreme views.” Eventually, the government relented and published the financial conflicts for the members of SAGE. In the final story of the series Thacker looked at the panels that the US and UK governments used to authorize vaccines and revealed that ... disclosure policies were inadequate. Some experts evaluating the vaccines had significant industry ties that were not disclosed.
Note: Read the full text of Thacker’s article titled, “Covid-19: How independent were the US and British vaccine advisory committees?” and another titled “How the case of the Oxford professor exposes a transparency crisis in government.” For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus from reliable major media sources.
Important Note: Explore our full index to key excerpts of revealing major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
